Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis [Phase 2]
A Phase 2 clinical trial investigating ABBV-105 alone or with Upadacitinib (ABBV-599) in active rheumatoid arthritis has completed with resu…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease [Phase 3]
Phase 3 trial comparing two dosing regimens of olokizumab (OKZ) to placebo and adalimumab in methotrexate-treated rheumatoid arthritis with …
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics
A completed clinical trial comparing outcomes of Xeljanz with biologics in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis [Phase 2]
Phase IIb dose-ranging study in moderate to severe rheumatoid arthritis has completed; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-09Clinical Trial Update: Study of Adalimumab to Lower Cardiovascular Risk in RA Patients With Well Controlled Joint Disease [Phase 4]
Phase 4 study updating on adalimumab to lower cardiovascular risk in rheumatoid arthritis patients with well-controlled joint disease has co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: A Double-Blind Study Evaluating Duvelisib in Subjects With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Alone [Phase 2]
Phase 2 double-blind trial evaluating duvelisib in patients with moderate to severe rheumatoid arthritis who have inadequate response to met…
-
CLINICAL_TRIALS trial_result · 2021-03-16Clinical Trial Update: Rheumatoid Arthritis Satisfaction Outcome Research
Clinical trial update for rheumatoid arthritis; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: A Study Comparing LBAL to Humira® in Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy [Phase 3]
Phase 3 trial comparing LBAL to Humira in patients with active rheumatoid arthritis despite methotrexate therapy has completed.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Effect of Subcutaneous ACTEMRA on Inflamed Atherosclerotic Plaques in Patients With Rheumatoid Arthritis [Phase 4]
Phase 4 trial assessing subcutaneous ACTEMRA (tocilizumab) on inflamed atherosclerotic plaques in patients with rheumatoid arthritis was ter…
-
CLINICAL_TRIALS trial_result · 2021-02-03Clinical Trial Update: Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel [Phase 3]
Phase 3 trial update comparing etanercept and Enbrel for rheumatoid arthritis, focusing on efficacy, safety, and immunogenicity.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA [Phase 3]
Phase 3 trial update comparing CinnoRA to Humira for active rheumatoid arthritis completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-01-26Clinical Trial Update: TOward the Lowest Effective DOse of Abatacept or Tocilizumab [Phase 4]
Phase 4 trial updating on achieving the lowest effective dose of abatacept or tocilizumab for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-01-20Clinical Trial Update: Optimization of Infliximab Withdrawal Strategy for Rheumatoid Arthritis [Phase 4]
Phase 4 trial update on optimizing withdrawal strategy of infliximab for rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-01-19Clinical Trial Update: Filgotinib in Combination With Methotrexate in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate [Phase 3]
Phase 3 trial update for filgotinib in combination with methotrexate in adults with moderately to severely active rheumatoid arthritis who h…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Filgotinib Alone and in Combination With Methotrexate (MTX) in Adults With Moderately to Severely Active Rheumatoid Arthritis Who Are Naive to MTX Therapy [Phase 3]
Phase 3 trial update on filgotinib alone and with methotrexate in adults with moderately to severely active rheumatoid arthritis who are MTX…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment [Phase 3]
Phase 3 trial assessing filgotinib versus placebo in adults with active rheumatoid arthritis after inadequate response to biologic DMARDs; r…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: ACTHAR for Acute Treatment of Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate [Phase 2]
Phase 2 clinical trial of ACTHAR for acute treatment in rheumatoid arthritis patients with inadequate response to methotrexate was terminate…
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Effect of Baricitinib Treatment on Peripheral Bone in RA [Phase 3]
Phase 3 trial investigating the effect of baricitinib on peripheral bone in rheumatoid arthritis patients.
-
CLINICAL_TRIALS trial_result · 2021-01-15Clinical Trial Update: Study to Evaluate the Pharmacokinetics of Filgotinib in Participants With Impaired Hepatic Function [Phase 1]
Phase 1 pharmacokinetics study of filgotinib in participants with impaired hepatic function completed.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX [Phase 3]
Phase 3 study evaluating SM03 in active rheumatoid arthritis patients on MTX.
-
CLINICAL_TRIALS trial_result · 2021-01-08Clinical Trial Update: Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain [NA]
A completed Brigham and Women's Hospital trial evaluated the effects of vitamin D and fish oil on autoimmune inflammation and knee pain; res…
-
CLINICAL_TRIALS trial_result · 2021-01-07Clinical Trial Update: A Study to Evaluate the Pharmacokinetics of Abatacept Converted From Drug Substance by Two Different Processes [Phase 1]
Phase 1 pharmacokinetic study evaluating abatacept converted from drug substance by two processes; completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: CF101 Therapy Compared to Methotrexate Therapy for Active Rheumatoid Arthritis [Phase 3]
Phase 3 trial comparing CF101 to methotrexate for active rheumatoid arthritis was terminated.
-
CLINICAL_TRIALS trial_result · 2020-12-19Clinical Trial Update: Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission [Phase 3]
Phase 3 trial comparing etanercept monotherapy to methotrexate monotherapy for maintenance of remission in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2020-12-04Clinical Trial Update: A Study to Evaluate Ocrelizumab Compared With Placebo in Patients With Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate Therapy [Phase 3]
Phase 3 trial evaluating ocrelizumab versus placebo in rheumatoid arthritis patients with inadequate response to methotrexate was terminated…